-
Product Insights
Metabolic Acidosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Metabolic Acidosis Global Clinical Trials Review, H2, 2017" provides an overview of Metabolic Acidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Acidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Mixed Dyslipidemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Mixed Dyslipidemia Global Clinical Trials Review, H2, 2017" provides an overview of Mixed Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Mixed Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Abdominal Obesity Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Abdominal Obesity Global Clinical Trials Review, H1, 2017" provides an overview of Abdominal Obesity clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Obesity. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Amyloidosis Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2017" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
EpiCast Report: Diabetic Foot Ulcers – Epidemiology Forecast to 2025
Diabetic foot ulcers (DFUs) are a common and disabling condition among people with diabetes. Globally, the prevalence of DFU among people with diabetes varies widely, ranging from 5.1% in the UK to approximately 11.9% in Algeria. The lifetime risk of developing a DFU in an individual with diabetes is approximately 25%. DFUs have become an increasingly significant public health concern in both the developed and the developing world, and are a major cause of hospitalizations and the leading cause of...
-
Product Insights
Hypertriglyceridemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypertriglyceridemia Global Clinical Trials Review, H2, 2017" provides an overview of Hypertriglyceridemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hyperuricemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hypovolemia (Hypovolaemia) Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hypovolemia (Hypovolaemia) Global Clinical Trials Review, H2, 2017" provides an overview of Hypovolemia (Hypovolaemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Hypovolemia (Hypovolaemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Insulin Resistance Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H2, 2017" provides an overview of Insulin Resistance clinical trials scenario. This report provides top line data relating to the clinical trials on Insulin Resistance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Type 2 Diabetes: Competitive Landscape to 2026
Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition heavily influenced by diet and lifestyle. Insulin is a hormone that regulates the glucose level in blood. Raised blood sugar (hyperglycemia) is an immediate consequence of diabetes, and over time leads to serious tissue damage, affecting the heart, blood vessels, eyes, kidneys, and nerves. This report provides an assessment of the pipeline, clinical, and commercial landscape of T2D. Overall,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.